Wellstar International Inc. subsidiary Trillenium Medical Imaging (TMI) today announced the development of its new clinical imaging system. The company said the camera design and technology used in clinical trials to detect patterns of injury associated with the development of pressure ulcers demonstrated that the patterns were detected before being clinically visible remains the same.
However, additional features and benefits leverage the imaging as a solid solution for healthcare facilities concerned with patient safety and looking for ways to reduce pressure ulcer occurrence.
John Antonio, president and CEO of TMI, said that TMI can integrate the camera into existing health information systems.
“By designing our own clinical version of the camera, we will control all aspects of our Imaging System and have the flexibility to incorporate all of the necessary functions to provide an innovative, bedside solution for the early detection of pressure ulcers. We will be able to seamlessly integrate into any Health Information System (HIS) that uses a barcode for patient identification, get immediate, real time analysis of the images at the bedside, and provide a means of documentation and data storage for the facility.”
The technology provides health care officials with a low-cost, multi-faceted tool that determines if a specific anatomic location has patterns of injury associated with the development of a pressure ulcer; provides the nursing staff and physicians with an immediate bedside analysis so that best practices can be implemented to prevent further skin damage and pressure ulcers; and provides documentation to the administration that includes data interpretation of the image, time the image was acquired, and a full report analysis that can be attached to the patients’ permanent record.
“This will be a valuable tool in assessing patients that are admitted to a facility, daily skin assessments, and documenting patient condition upon discharge. This will provide patients with the highest level of care, while documenting every aspect of the process for the facility,” Antonio stated.
The development process of the camera is already complete, and four prototypes are scheduled to be delivered in June. The company said it anticipates unveiling the final clinical version in October.
For more information on the company, visit www.wellstar.us
Let us hear your thoughts below:
